Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy

Annals of Pharmacotherapy

Volumn 38, Issue 12, 2004, Pages 2050-2054

  Molia, Aurélie C ^a   Strady, Christophe ^a   Rouger, Christine ^a   Beguinot, Isabelle M ^a   Berger, Jean Luc ^a   Trenque, Thierry C ^b  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b Pharmacovigilance Regional Center   (France)

Author keywords

Avascular necrosis of bone; Bone diseases; HIV; Osteonecrosis; Protease inhibitors; Risk factors

Indexed keywords

CORTICOSTEROID; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PARACETAMOL; PROTEINASE INHIBITOR; SAQUINAVIR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; ANKLE PAIN; ARTICLE; AVASCULAR NECROSIS; BODY MASS; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP ARTHROPLASTY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE; TALUS; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FEMUR HEAD NECROSIS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 12844281781     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E154     Document Type: Article

References (22)

1. Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS 2003;17:1-9.
2. Roudière L, Viard JP. Osteonecrosis of the hip, lipodystrophy and antiretroviral treatment (letter). AIDS 2000;14:2056.
3. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy (abstract). AIDS 2000;14:F63-7.
4. Brown P, Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin Infect Dis 2001;32:1221-6.
5. Lee CK, Hansen HT, Weiss AB. The "silent hip" of idiopathic ischemic necrosis of the femoral head in adults. J Bone Joint Surg Am 1980;62:795-800.
6. Sighinolfi L, Carradori S, Ghinelli F. Avascular necrosis of the femoral head: a side effect of highly active antiretroviral therapy (HAART) in HIV patients? Infection 2000;28:254-5.
7. Blacksin MF, Kloser PC, Simon J. Avascular necrosis of bone in human immunodeficiency virus infected patients. Clin Imaging 2000;23:314-8.
8. Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J Infect Dis 2001;184:519-23.
9. Monier P. Can the bone disease experienced by HIV-infected patients be attributed to HAART? HIV Clin 2003;15:1-3.
10. Meyer D, Behrens G, Schmidt RE, Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS 1999;13:1147-8.
11. Gutierrez F, Padilla S, Ortega E, Garcia JA, Flores J, Galera C, et al. Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. AIDS 2002;16:481-95.
12. Bonfanti P, Gabbuti A, Carradori S, Pusterla L, Parazzini F, Landonio S, et al. Osteonecrosis in protease inhibitor-treated patients. Orthopedics 2001;24:271-2.
13. Monier P, McKown K, Bronze MS. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis 2000;31:1488-92.
14. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-19.
15. Scribner AN, Troia-Cancio PV, Cox BA, Marcantonio D, Hamid F, Keiser P, et al. Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr 2000;25:19-25.
16. Keruly JC, Chaisson RE, Moore RD. Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J Acquir Immune Defic Syndr 2001;28:101-2.
17. Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 2003;36(suppl 2):S101-5.
18. Skiest DJ. Osteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution. Clin Infect Dis 2001;33:268-9.
19. Calza L, Manfredi R, Mastroianni A, Chiodo F. Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review. AIDS Patient Care STDS 2001;15:385-9.
20. Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002;137:17-24.
21. Koller E, Mann M, Malozowski S, Bacsanyi J, Gibert C. Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate. AIDS Patient Care STDS 2000;14:405-10.
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.